Clinical management of renal transplant patients with hepatitis C virus infection treated with Cyclosporine or Tacrolimus

被引:8
作者
Latorre, A [1 ]
Morales, E [1 ]
Gonzalez, E [1 ]
Herrero, JC [1 ]
Ortiz, M [1 ]
Sierra, P [1 ]
Dominguez-Gil, B [1 ]
Torres, A [1 ]
Munoz, MA [1 ]
Andres, A [1 ]
Manzanares, C [1 ]
Morales, JM [1 ]
机构
[1] Biochem & Nephrol Dept, Madrid, Spain
关键词
D O I
10.1016/S0041-1345(01)02678-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:63 / 64
页数:2
相关论文
共 4 条
[1]   METABOLISM OF CYCLOSPORINE AFTER ORTHOTOPIC LIVER-TRANSPLANTATION [J].
FABRE, JM ;
PEDROSA, R ;
BONARDET, A ;
PICHARD, L ;
DESCOMPS, B ;
DOMERGUE, J ;
BAUMEL, H ;
MAUREL, P .
BIOCHEMICAL PHARMACOLOGY, 1993, 46 (07) :1151-1157
[2]   INCREASED SUSCEPTIBILITY FOR CSA-INDUCED HEPATOTOXICITY IN KIDNEY GRAFT RECIPIENTS WITH CHRONIC VIRAL-HEPATITIS-C [J].
HORINA, JH ;
WIRNSBERGER, GH ;
KENNER, L ;
HOLZER, H ;
KREJS, GJ .
TRANSPLANTATION, 1993, 56 (05) :1091-1094
[3]  
KARANAM BV, 1994, DRUG METAB DISPOS, V22, P811
[4]   Influence of hepatitis C virus infection on FK 506 blood levels in renal transplant patients [J].
Manzanares, C ;
Moreno, M ;
Castellanos, F ;
Cubas, A ;
Herrero, JC ;
Morales-Ruiz, E ;
Segura, J ;
Andres, A ;
Morales, JM .
TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) :1264-1265